ROIV ▲ +1.6% - Roivant Sciences Ltd. $ROIV highs continue off FDA earlier release Roivant Sciences stock extended its gains today, rising 1.6%, as investors continued to react positively to an earlier FDA announcement. The headline suggests the stock has been climbing following the regulatory agency's decision, though specific details about the FDA's action are not provided in the headline itself. 27-AUG-2026 03:28 PM ET